Over 10,000 customers have rated this store since 1999
Glucosamine + Chondroitin (90 capsules)
GL6
(30 Day Supply)
IN STOCK - YES
What is Glucosamine + Chondroitin? Glucosamine promotes the repair of cartilage. Chondroitin promotes water retention and elasticity in cartilage, and inhibits enzymes that break down cartilage.
The combination of 1500mg Glucosamine Sulfate and 1200mg Chondroitin Sulfate that is provided by a one day supply of our product is the same combination that was used in the ground breaking US National Institute of Health, "GAIT" study published in the New England Journal of Medicine! 1
Who Should Consider Glucosamine + Chondroitin? Anyone who is experiencing Osteoarthritis joint-associated pain, including:
Knee joint pain;
Elbow joint pain;
Finger, joint pain;
Spinal and neck related Osteoarthritic pain;
Hip related Osteoarthritic pain;
Other related joint/cartilage pain stemming from Osteoarthritis.
Why:
To slow the progression of osteoarthritis (the deterioration of cartilage between joint bones), to reduce the associated arthritis pain, and to help revitalize the cellular components within the joints. Glucosamine promotes the formation and repair of cartilage. Chondroitin promotes water retention and elasticity in cartilage, and inhibits enzymes that break down cartilage.
To be sure you never run out of your favorite products, we now offer our exclusive
Convenience Plan. This plan guarantees delivery of our
high quality products directly
to your door exactly when you need them. Additionally, you receive our lowest price on
each order. It is simple, convenient and free! And, you can change, add to, suspend or
cancel shipments at any time!
Background on Ingredients:
Osteoarthritis, a type of degenerative joint disease, is the most common type of arthritis. It is characterized by a breakdown of cartilage in joints and can occur in almost any joint in the body. Most commonly it occurs in the fingers, hips, knees and spine.
Cartilage is a firm, rubbery material that covers the ends of bones in normal joints. The main function of cartilage is to reduce friction in the joints and serve as a "shock absorber." The shock-absorbing quality of normal cartilage comes from its ability to change shape when compressed (flattened or pressed together).
Osteoarthritis causes the cartilage in a joint to become stiff and lose its elasticity, making it more prone to damage. Over time, the cartilage may deteriorate in some areas, greatly decreasing its ability to act as a shock absorber. As the cartilage wears away, tendons and ligaments stretch, causing pain. If the condition worsens, the bones could rub against each other.
How Does Glucosamine Work?
Glucosamine and chondroitin are components of normal cartilage. In the body, they are the building blocks for cartilage and appear to stimulate the body to make more cartilage.
Healthy cartilage needs three things: water for lubrication and nourishment, proteoglycans to attract and hold the water, and collagen to keep the proteoglycans in place.
Proteoglycans are like a rope that threads itself through the collagen. They are essential as they hold many times their own weight of water, which both lubricates and nourishes the collagen. If the cartilage is damaged the thread of rope becomes weak and ‘leaks’ out causing the collagen to lose its nourishment as the proteoglycans lose their grip and float away. Thus the cartilage cannot withstand shocks or cracks and may wear out completely.
Common treatments don't change the progression of osteoarthritis. Because these supplements stimulate the production of new cartilage, it is thought that they may be able to help the body repair damaged cartilage.
Glucosamine has been studied for well over 40 years in humans. It has been shown in numerous clinical studies to regrow cartilage, slow the progression of arthritis, and possibly even modify the disease itself with almost no side effects.
The main function of glucosamine is to stimulate the body’s own ability to manufacture substances like cartilage and collagen, necessary for joint repair. Some people lack the ability to manufacture glucosamine and this has been suggested as one of the major factors leading to the development of osteoarthritis. European researchers were the first to study the link between glucosamine levels and osteoarthritis. Of the ingredients in Glucosamine + Chondroitin, Glucosamine has the strongest amount of research indicating its efficacy. If you are on a tight budget, Glucosamine alone is a less expensive option. Click here to go to our most popular Glucosamine only product.
How Does Chondroitin Work?
Where glucosamine helps form the proteoglycans that sit within the space in the cartilage, chondroitin sulphate acts like a ‘liquid magnet’. Chondroitin is a long chain of repeating nigans that attracts fluid into the proteoglycan molecules. The fluid acts as a spongy shock absorber, and sweeps the nutrients into the cartilage.
Joint cartilage has no blood supply. All of its nourishment and lubrication comes from the fluid that ebbs and flows as pressure is applied and released to the joint. Without this fluid, cartilage would become malnourished, drier, thinner and more fragile.
Chondoitin Sulphate is a long chain molecule with a negative charge attached to it. As these chains wrap around proteoglycans they repel each other and create spaces between each proteoglycan. These are what are known as matrixes within the cartilage and this is where the fluid flows. There may be as many as 10,000 of these chains on a single proteoglycan molecule, which makes for a great water retainer as these chains make sure all the molecules are repelled away from each other and cannot clump together.
Besides drawing in fluid, chondroitin protects cartilage and stops it from breaking down. It also inhibits certain ‘cartilage chewing’ enzymes, interferes with the metabolism of other enzymes that will starve the cartilage of fluid, and stimulates production of proteoglycans, glucosamine and collagen.
While Glucosamine helps you manufacture or repair cartilage, Chondroitin seems to help maintain its health and lubrication.
Recent Research on Chondroitin is compelling.
For the past seven years we have not sold a product with Chondroitin in it. We have refrained from selling Chondroitin mainly because the research on the efficacy of orally consumed Chondroitin, although building, was not yet compelling. We are now firmly of the opinion that, based on numerous double-blind placebo, controlled studies, adding chondroitin to your supplement regime is a strongly positive factor in reducing the negative effects of Osteoarthritis.
Side Effects Low. Potential users who take blood-thinning agents should review with their physicians before using. NOTE TO THOSE WITH SHELLFISH ALLERGIES: In the June 2004 Edition of the "Drugs and Therapy Bulletin" from Shands at the University of Florida, they stated that most warnings to not use glucosamine if you have a shellfish allergy are based on the assumption that a patient that is allergic to shellfish may also be allergic to glucosamine since glucosamine is made from shellfish. However, this article goes on to state that this warning may be conservative since the antigens in crustaceans and mollusks are proteins and not derivatives of their shells. Also, there have been no published reports about patients with shellfish allergies having negative reactions to glucosamine supplements. However, there are reports of patients experiencing hypersensitivity to glucosamine, so please consult with your physician if you have ever experienced an adverse reaction to glucosamine. (For more information about this study, please visit www.shands.org/professional/drugs/bulletins/0604.pdf
Label Facts
Glucosamine + Chonroitin, 90 capsules:
Supplement Facts Serving Size: 3 Capsules Servings per container: 30
Amount Per Serving
% Daily Value
Sodium (from Chondroitin Sodium Sulfate)
108 mg
4.5%
Potassium (from Glucosamine Potassium Sulfate)
240 mg
6.9%
Glucosamine Sulfate KCl
1500 mg
†
Chondroitin Sodium Sulfate
1200 mg
†
†Daily value not established.
Other ingredients: Modified cellulose, magnesium stearate (vegetable source).
Vcaps vegetarian capsule used but not a vegetarian formula.
References
Clegg, D. O., D. J. Reda, et al. (2006). "Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis." N Engl J Med 354(8): 795-808.
D'Ambrosio, E., B. Casa, R. Bompani, G. Scali and M. Scali (1981). "Glucosamine sulphate: a controlled clinical investigation in arthrosis." Pharmatherapeutica 2(8): 504-8.
Leffler, C. T., A. F. Philippi, S. G. Leffler, J. C. Mosure and P. D. Kim (1999). "Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study." Mil Med 164(2): 85-91.
McAlindon, T. E., M. P. LaValley, J. P. Gulin and D. T. Felson (2000). "Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis [see comments]." Jama 283(11): 1469-75.
Pujalte, J. M., E. P. Llavore and F. R. Ylescupidez (1980). "Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis." Curr Med Res Opin 7(2): 110-14.
Vajaradul, Y. (1981). "Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis." Clin Ther 3(5): 336-43.
Drovanti, A. et. al.; Therapeutic Activity of Oral Glucosamine Sulfate in Osteoarthritis: A Placebo-Controlled, Double-Blind Investigation; Clinical Therapeutics, Vol. 3, No. 4, 1980, pp. 260-272
Reginster, Jean Yves et. al.; Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial; The Lancet, 2001, Vol. 357, No. 9252
Morreale, P. et. al.; Comparison of the Antiinflammatory Efficacy of Chondroitin Sulfate and Diclofenac Sodium in Patients with Knee Osteoarthritis; Journal of Rheumatology, 1996, 23:8, pp. 1385-1391
Bourgeois P, et al. Efficacy and tolerability of chondroitin sulfate 1200 mg a day versus chondroitin sulfate three times 400 mg a day versus placebo. Osteoarthritis and Cartilage 1998;69(A):25-30.
Vergruggen G, et al. Chondroitin sulfate: structure/disease modifying antiarthritis drug in the treatment of finger joint OA. Osteoarthritis and Cartilage 1998;6(A):37-8.
Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis in the treatment of knee osteoarthritis. Osteoarthritis and Cartilage 1998;6(A):31-6.
Uebelhart D. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis and Cartilage 1998;68(A):39-46.
Uebelhart D, Thonar EJ, Delmas PD, Chantraine A, Vignon E., Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Department of Neuclid, University Hospital of Geneva, Switzerland.
Bucsi L, Poor, G., Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage. 1998 May;6 Suppl A:31-6.
Bourgeois P, Chales G, Dehais J, Delcambre B, Kuntz JL, Rozenberg S., Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Arch Intern Med. 2004 Feb 9;164(3):338-9; author reply 339.
Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Drugs Exp Clin Res. 2004;30(1):11-6.
Rovetta G, Monteforte P, Molfetta G, Balestra V. A two-year study of chondroitin sulfate in erosive osteoarthritis of the hands: behavior of erosions, osteophytes, pain and hand dysfunction. Osteoarthritis Cartilage. 2004 Apr;12(4):269-76.
Uebelhart D, Malaise M, Marcolongo R, DeVathaire F, Piperno M, Mailleux E, Fioravanti A, Matoso L, Vignon E. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. J Rheumatol. 2001 Jan;28(1):173-81.
Reginster J-Y, Deroisy R, Paul I, Lee RL, Henroitoin Y, Giacovelli G, et al. Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years: a large, randomised, placebo-controlled, prospective trial. Arthritis Rheum 1999;42:S400.
Pavelka K, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate decreases progression of knee osteoarthritis in a long-term randomised placebo-controlled trial. Arthritis Rheum 2000;43:S384.
Glucosamine and Chondroitin References / Additional Resources
(1998). "[Gonarthrosis--current aspects of therapy with glucosamine sulfate (dona200-S)]." Fortschr Med Suppl 183: 1-12.
(1999). "Glucosamine sulfate." Altern Med Rev 4(3): 193-5.
Baici A et al. Analysis of gylcosaminoglycans in human sera after oral administration of chondroiton sulfate. Rheumatol Int 1992. 12:81-8.
Bassleer, C., L. Rovati and P. Franchimont (1998). "Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro." Osteoarthritis Cartilage 6(6): 427-34.
Conte A et al. Biochemical and pharmacokinetic aspects of oral treatment with chondroiton sulfate. Arzneim Forsch. 1995. 45:918-25.
D'Ambrosio, E., B. Casa, R. Bompani, G. Scali and M. Scali (1981). "Glucosamine sulphate: a controlled clinical investigation in arthrosis." Pharmatherapeutica 2(8): 504-8.
da Camara, C. C. and G. V. Dowless (1998). "Glucosamine sulfate for osteoarthritis [see comments]." Ann Pharmacother 32(5): 580-7.
Houpt, J. B., R. McMillan, C. Wein and S. D. Paget-Dellio (1999). "Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee [see comments]." J Rheumatol 26(11): 2423-30.
Kelly, G. S. (1998). "The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease." Altern Med Rev 3(1): 27-39.
McAlindon, T. E., M. P. LaValley, J. P. Gulin and D. T. Felson (2000). "Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis [see comments]." Jama 283(11): 1469-75.
McCarty, M. F. (1998). "Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis." Med Hypotheses 50(6): 507-10.
Murray, Michael, ND, Pizzorno, Joseph, ND. Encyclopedia of Natural Medicine, second ed. Prima Publishing, Rocklin. 1998.
Qiu, G. X., S. N. Gao, G. Giacovelli, L. Rovati and I. Setnikar (1998). "Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis." Arzneimittelforschung 48(5): 469-74.
Setnikar et al. Pharmacokinetics of glucosamine in man. Arzneim Forsch. 1993. 43(10):1109-13.
Tapadinhas, M. J., I. C. Rivera and A. A. Bignamini (1982). "Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal." Pharmatherapeutica 3(3): 157-68.
Vidal y Plana, R. R. and K. Karzel (1980). "[Glucosamine: its importance for the metabolism of articular cartilage. 2. Studies on articular cartilage]." Fortschr Med 98(21): 801-6.
Mindell, E. L., The MSM Miracle: Enhance your health with organic sulfur. Keats Publishing, New Canaan, CT, 1997.
Bartfeld, I. J., Goldstein, A., "Cell-mediated Immunity: Its Modulation by Dimethylsulfoxide," Ann. N. Y. Acad. Sci., 1975.
Childs, S. J., "Dimethylsulfone (DSM02) in the Treatment of INterstitial Cystitis." Urol. Clin. North Am., 1994.
Cooper, A., "Biochemistry of Sulfur-containing Amino Acids," Ann. Rev. Biochem., 1983.
D'Ambrosia, E, Casa, B., Bompani R., Scali, M., "Glucosamine Sulphate: A Controlled Clinical Investigation in Arthosis," Pharmatherapeutica, 1981.
Herschler, R. J., "Methysulfonylmethane and Methods of Use," United States Patent 4,296,130: 1981.
Herschler, R. J., "Methysulfonylmethane and Compositions Comprising It," United States Patent 4,616,039: 1986.
Herschler, R. J., "Dietary and Pharmaceutical uses of Methysulfonylmethane Compositions Comprising It," United States Patent 4,512,421:
Jacob, S. W., "The Current Status of MSM in Medicine," Am. Acad. Meri. Prev., 1983.
Jacob, S. W., Herschler R. J., "Introdry Remarks: Dimethylsulfoxide After Twenty Years," Ann. N. Y. Acad. Sci., 1983.
Kharasch, N., Thyagarajan, B. S., "Structural Basis for Biological Activities of Dimethylsulfoxide," Ann. N. Y. Acad. Sci., 1983.
Klein, H. A., Samant, S., Herz, B. L., Pearlman, H. S., "Dimethylsulfoxide in Adult Respiratory Stress Syndrome," Ann. N. Y. Acad. Sci., 1983.
Koesis, J. J., Harkaway, S, Snyder, R., "Biological Effects of the Metabolites of Dimethylsulfoxide," Ann. N. Y. Acad. Sci., 1975.
Metcalf, J. W., "MSM--A Dietary Derivative of DSMO," J. Eq. Vet. Sci., 1983.
Metcalf, J. W., "MSM Status Report," Eq. Vet. Data, 1986.
Miura K et al., "Cystine Uptake and Glutathione Level in Endothelial Cells Exposed to Oxidative Stress," Am. J. Physiol., 1992.
Morton, J. i., Siegel, B. V., "Effects of Oral Dimethylsulfoxide and Dimethylsulfone on Murine Autoimmune Lymphoproliferative Disease," Proc. Soc. Exper. Bio. Med., 1986.
Nagasawa, H., "The In Vitro and In Vivo EffectS Dimethylsulfoxide on the Pituitary Secretion of Growth Hormone and Prolactin in Mice," Ann. N. Y. Acad. Sci., 1983.
Pearson, T. W., Dawson, H. J., Lackey, H. B., "Natural Occurring Levels of Dimethylsulfoxide in Selected Fruits, Vegetables, Grains and Beverages," J. Agric. Food Chem., 1981.
Repine, J. E., Fox, R. B., Berger, E. M., "Effect of Dimethylsulfoxide on the Bactericidal Function of Polymorphonuclear Leukocytes," Ann. N.Y. Acad. Sci., 1983.
Richmond , V. L., "lncorporation of Methylsulfonylmethane Into Guinea Pig Serum Proteins," Life Sciences, 1986.
Richmond , V. L., "Incorporation of Methylsulfonylmethane into Guinea Pig IgG, Transferrin and Albumin Fractions and Tissues," Seattle, Wash: Pacific Northwest Research Foundation.
Sellnow, I., "MSM--An Aid From Nature," Canadian Horseman, 1989.
Tapadinhas, M. J., Rivera, I. C., Bignamini, A. A., "Oral Glucosamine Sulfate in the Management of Arthrosis," Report on a Multi-center Open Investigation in Portugal, 1982. IL
Teigland, M. B., Saurino, V. R., "Clinical Evaluation of Dimethylsulfoxide in Equine Applications," Ann. N. Y. Acad. Sci., 1975.
Voaden. M. J; Hussain. A.A.; Chan, I. P. R. "Studies on Retinitis Pigmentosa in Man. I. Taurine and Blood Platelets." Brit. J. Opthal., 1982.
Williamson, J., Boettcher, B., Meister, A., "lntracellular Cysteine Delivery System that Protects Against Toxicity by Promoting Glutathione Synthesis," Proc. Nat. Acad. Sci., 1982.
Wright, J., Littleton, K., "Defects in Sulfur Metabolism," Intl. Clin. Nutr. Rev., 1989.
Wright, J., Kirk, F. R., "Defects in Sulfur Metabolism II: Apparent Failure of Sulphate Conjugation," Intl. Clin. Nutr. Rev., 1989.
Ronca F, et al. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis and Cartilage 1998;69(A):14-21.
Bucci LR. Pain-Free. Ft. Worth, TX: The Summit Group, 1995.
Theodosakis, Adderly, and Fox. The Arthritis Cure. New York: St. Martin's Press, 1997.
Theodosakis, Jason, Better Nutrition, May 2002.
Priebe, David, McDiarmid, Todd, Mackler, Leslie, “ Do glucosamine or chondroitin cause regeneration of cartilage in osteoarthritis?”, Journal of Family Practice
Hauselmann, HJ. Nutripharmaceuticals for osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15:595-607.
de los Reyes GC, Koda RT, Lien EJ. Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey. Prog Drug Res 2000; 155:81-103.
Jubb, RW. Oral and intra-articular remedies: review of papers published from March 2001 to February 2002. Curr Opin Rheumatol 2002; 14:597-602.
Reginster, JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357:251-256.
Mazzuca SA, Brandt KD, Lane KA, Katz BP. Knee pain reduces joint space width in conventional standing antero-posterior radiographs of osteoarthritic knees. Arthritis Rheum 2002; 46:1223-1227.
Verbruggen, G, Goemaere S, Veys EM. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin Rheumatol 2002: 21:231-243.
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000; 43:1905-1915.
Problems with dietary supplements. Med Lett Drugs Ther 2002; 44:84-86.
McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis. JAMA 2000;283:1469-75.
van Blitterswijk WJ, van de Nes JC, Wuisman PI, Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report, BMC Complement Altern Med. 2003 Jun 10;3(1):2.
Hungerford DS, Jones LC, Glucosamine and chondroitin sulfate are effective in the management of osteoarthritis, J Arthroplasty. 2003 April; 18 (2 Suppl 1):5-9.
This website and these statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Please consult a properly trained medical practitioner for medical advice.
